UAB "Renalfarma" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statement report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
Working capital requirement |
Debt-to-equity ratio |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2022 |
---|
1,921,403 |
320,234 |
65,006 |
56,157 |
9,360 |
37.36 |
2.92 |
266,333 |
477,046 |
135,441 |
604,633 |
2023 |
---|
2,053,315 |
342,219 |
154,130 |
131,571 |
21,929 |
37.20 |
6.41 |
356,905 |
275,860 |
104,683 |
525,517 |
2024 |
---|
2,010,833 |
389,696 |
188,260 |
161,594 |
31,317 |
40.65 |
8.04 |
398,499 |
267,819 |
75,338 |
588,206 |
Register and
explore Okredo data2024 |
---|
2,010,833 |
389,696 |
188,260 |
161,594 |
31,317 |
40.65 |
8.04 |
398,499 |
267,819 |
75,338 |
588,206 |
Register and
explore Okredo data2024
Turnover (€)
2,010,833 €-2 % *
Sales per employee (€)
389,696 €14 % *
Profit before tax (€)
188,260 €22 % *
Net Profit (€)
161,594 €23 % *
Profit per employee (€)
31,317 €43 % *
Total profitability (%)
40.65 %9.27 % *
Net profitability (%)
8.04 %25.43 % *
Equity (€)
398,499 €12 % *
Amounts Payable And Liabilities (€)
267,819 €-3 % *
Non-current Assets (€)
75,338 €-28 % *
CurrentAssets (€)
588,206 €12 % *